Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment by Martín, Verónica et al.
BioMed  Central
Page 1 of 12
(page number not for citation purposes)
BMC Genomics
Open Access Methodology article
Microarray-based identification of antigenic variants of 
foot-and-mouth disease virus: a bioinformatics quality assessment
Verónica Martín1, Celia Perales1, David Abia2, Angel R Ortíz2, 
Esteban Domingo*1 and Carlos Briones3
Address: 1Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, Cantoblanco, 28049, Madrid, Spain, 2Bioinformatics 
Unit, Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, Cantoblanco, 28049, Madrid, Spain and 3Centro de 
Astobiología (CSIC-INTA), Torrejón de Ardoz, 28850, Madrid, Spain
Email: Verónica Martín - vmartin@cbm.uam.es; Celia Perales - cperales@cbm.uam.es; David Abia - dabia@cbm.uam.es; 
Angel R Ortíz - aro@cbm.uam.es; Esteban Domingo* - edomingo@cbm.uam.es; Carlos Briones - brioneslc@inta.es
* Corresponding author    
Abstract
Background: The evolution of viral quasispecies can influence viral pathogenesis and the response
to antiviral treatments. Mutant clouds in infected organisms represent the first stage in the genetic
and antigenic diversification of RNA viruses, such as foot and mouth disease virus (FMDV), an
important animal pathogen. Antigenic variants of FMDV have been classically diagnosed by
immunological or RT-PCR-based methods. DNA microarrays are becoming increasingly useful for
the analysis of gene expression and single nucleotide polymorphisms (SNPs). Recently, a FMDV
microarray was described to detect simultaneously the seven FMDV serotypes. These results
encourage the development of new oligonucleotide microarrays to probe the fine genetic and
antigenic composition of FMDV for diagnosis, vaccine design, and to gain insight into the molecular
epidemiology of this pathogen.
Results: A FMDV microarray was designed and optimized to detect SNPs at a major antigenic site
of the virus. A screening of point mutants of the genomic region encoding antigenic site A of FMDV
C-S8c1 was achieved. The hybridization pattern of a mutant includes specific positive and negative
signals as well as crosshybridization signals, which are of different intensity depending on the
thermodynamic stability of each probe-target pair. Moreover, an array bioinformatic classification
method was developed to evaluate the hybridization signals. This statistical analysis shows that the
procedure allows a very accurate classification per variant genome.
Conclusion: A specific approach based on a microarray platform aimed at distinguishing point
mutants within an important determinant of antigenicity and host cell tropism, namely the G-H loop
of capsid protein VP1, was developed. The procedure is of general applicability as a test for
specificity and discriminatory power of microarray-based diagnostic procedures using multiple
oligonucleotide probes.
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Background
The control of diseases associated with highly variable
RNA viruses requires close monitoring of the variant virus
types that periodically dominate in viral populations. This
is due to high mutation rates, quasispecies dynamics and
population bottlenecks that often accompany virus trans-
mission [reviewed in [1]]. Indeed, RNA viruses replicate
with mutation rates in the range of 10-3 to 10-5 substitu-
tions per nucleotide copied [2,3]. As a consequence, RNA
virus populations consist of complex and dynamic distri-
butions of related genomes termed viral quasispecies
[4,5]. Viral quasispecies can influence viral pathogenesis
[6-8], and the response to antiviral treatments [9]. Mutant
clouds in infected organisms represent the first stage in
the natural genetic and antigenic diversification of viruses
[8,10]. A consequence which is relevant to viral diagnosis
and surveillance is that a transmission bottleneck may
result in the establishment in the recipient host of one (or
few) variant(s) sampled from the mutant cloud that repli-
cates in the infected donor. Therefore, methodology to
discern among minor variants of the same viral genotype
or serotype is essential for epidemiological surveillance
and the planning of disease control strategies.
An important animal pathogen which participates of qua-
sispecies dynamics, transmission bottlenecks, and the
potential for rapid evolution is foot-and-mouth disease
virus (FMDV), the etiological agent of the economically
most devastating disease of farm animals [recent reviews
in [11]]. FMDV is an aphthovirus of the family Picornaviri-
dae, whose genome is a single stranded RNA of about
8200 nucleotides, of positive polarity, replicated by a
virus-coded RNA-dependent RNA polymerase, devoid of a
proofreading-repair activity [12]. The antigenic variation
of FMDV is a direct consequence of its genetic variation
during natural infections, confirmed by many experi-
ments in vivo and in cell culture [11,13]. Inactivated virus
vaccines are used to control FMD, but their efficacy is lim-
ited by the antigenic variation of the virus [11]. The anti-
genic diversity of FMDV is reflected in the occurrence of
seven serotypes (A, O, C, Asia1, SAT1, SAT2, SAT3), and
multiple subtypes and variants that defy classification due
to the continuous recognition of mutant forms in replicat-
ing FMDV quasispecies [14]. In vaccination-challenge
experiments no cross-protection is observed among repre-
sentatives of a different serotype, and only partial protec-
tion among some subtypes and variants [11]. Therefore,
continuous monitoring of circulating antigenic forms is
required to prepare vaccines whose antigenic composition
matches that of the circulating virus [11].
Antigenic variants of FMDV have been classically diag-
nosed by immunological methods (complement fixation,
ELISA, neutralization of infectivity) [review in [15]].
Recently, several methods based on reverse transcription-
PCR (RT-PCR) amplification have been adapted to the
diagnosis of FMDV [16]. Some of these methods can be
applied without the need to grow the virus in cell culture.
More recently, a FMD DNA chip containing 155 oligonu-
cleotide probes to detect simultaneously the seven FMDV
serotypes has been described [17]. Several studies have
documented that long oligonucleotide DNA microarrays
can detect simultaneously many viral pathogens [18].
Multiple oligoprobes were used to characterize the heter-
ogeneous composition and recombination forms of
human poliovirus [19]. These results encourage the devel-
opment of a new microarray-based approach to probe the
fine genetic and antigenic composition of FMDV for diag-
nosis, vaccine design, and to gain insight into the molec-
ular epidemiology of this pathogen.
A major antigenic site of FMDV (termed site A) is located
at the mobile, exposed G-H loop of capsid protein VP1
[13,20,21]. This loop includes several epitopes involved
in binding of neutralizing antibodies, as well as an Arg-
Gly-Asp (RGD) triplet that participates in recognition of
integrin receptors [21,22]. The overlap of residues
involved in receptor recognition and antibody binding
implies that variations at the G-H loop of VP1 can have
consequences both for the antigenic behavior of the virus
and its host range [23,24]. For FMDV of serotype C multi-
ple variants at the epitopes located within antigenic site A
were documented among natural populations of the
virus. Furthermore, studies in cell culture have shown that
FMDV can evolve towards variants with altered RGD that
display a remarkable expansion of host cell tropism [25].
The several biological implications of the G-H loop of VP1
prompted us to develop a DNA oligonucleotide microar-
ray to probe multiple genetic variants of FMDV, around
VP1 residues 139 to 147 (Figure 1). We report assay con-
ditions that have been optimized to detect the presence of
several point mutants at this major antigenic site of
FMDV, and develop a support vector machine (SVM)-
based procedure to automatize sample classification
hybridization intensities and to set up limits for reliable
diagnosis.
Results
Specificity and sensitivity optimization of FMDV 
microarray
In a first approach, 8 DNA oligonucleotides were designed
for the set up of an FMDV microarray. They represent RNA
sequences encoding the G-H (VP1) loop of C-S8c1 FMDV.
Two variants (encoding RGD and RED at VP1 positions
141–143) (Figures 1 and 2) of FMDV were initially tested.
A microarray with both FMDV variants was printed to
analyze the influence of long (15-mer) versus short (11-
mer) oligonucleotides, the presence or absence of (dT)15
spacers, and the oligonucleotide concentration. A number
of conclusions were drawn from the results (not shown).BMC Genomics 2006, 7:117 http://www.biomedcentral.com/1471-2164/7/117
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First, the hybridization signals were weaker with oligonu-
cleotides of 11 residues than with oligonucleotides of 15
residues. We have not assessed oligonucleotides longer
than 15 residues because they are more likely to accom-
modate, without destabilization of the helical duplex, a
single nucleotide mismatch at a central position [26]. The
second observation was that oligonucleotides linked
through a (dT)15 track hybridized more efficiently than
those without the track in agreement with previous results
[27]. Third, the experiments indicated that the amount of
oligonucleotide attached at concentrations between 5 and
50 µM was not limiting for detection of fluorescent DNAs.
We chose the highest concentration tested for the stand-
ard protocol. Preliminary experiments showed also that
hybridization solutions including 50% formamide
resulted in poor sensitivity, and that the Unyhib solution
(Arrayit) produced results comparable to those obtained
with the hybridization solution described in Methods. To
generate labeled targets, two different systems were used:
direct labeling with Cy3-dUTP and Cy5-dUTP, and indi-
rect labeling with Alexa Fluor 647; the latter proved easier,
more reproducible, efficient and yielded targets showing
higher stability.
A step-wise increase of hybridization temperatures,
between 48°C and 62°C, was tested. Low temperatures
resulted in poor microarray performance due to high
number of false positives. The optimal point mutation
discrimination was obtained between 58°C and 60°C.
Higher temperatures resulted in a progressive and signifi-
cant loss of signal. Similar comparisons revealed 45°C as
the most adequate temperature for washing the hybrid-
ized microarrays. A scheme of the entire procedure with
indication of the steps for which variables were screened
is depicted in Figure 3.
Screening of point mutants of the genomic region encoding 
antigenic site A of FMDV C-S8c1
A total of 11 positions within genomic residues 3616 to
3654 were analyzed by constructing 15-mer oligonucle-
otides with the queried nucleotide (and a number of neg-
ative control mismatched nucleotides) located at position
7 to 11 in each 15-mer (Figure 2). Forty-one oligonucle-
otides were spotted in duplicate, distributed in 4 rows and
12 columns per grid (Figure 4). A conserved FMDV
sequence was used as positive control for the hybridiza-
tion (ICF). Two unrelated HIV oligonucleotides (HIVa
and HIVb) and spots with no nucleotide (nn) were used
as negative control. The same pattern containing spots
with 15-mers corresponding to the different queried and
control mutants, and positive (ICF) and negative (HIV,
nn) controls were printed four times per slide.
RT-PCR products obtained with RNA from each of 16
mAb SD6-escape mutants of FMDV as template and prim-
ers 5'P-1R1L and pUL, were treated with lambda exonu-
Scheme of the FMDV genome and repertoire of mAb SD6-escape mutants included in the microarray Figure 1
Scheme of the FMDV genome and repertoire of mAb SD6-escape mutants included in the microarray. Top: C-
S8c1 genome (8115 nucleotides, excluding homopolymeric tracts); boxes indicate encoded proteins and lines indicate regula-
tory regions (not drawn to scale); the filled circle represents protein VPg covalently linked to the 5' end of the RNA, and 
AAAA represents the 3'-terminal polyadenylate tract. Below the genome, the amino acid sequence of the G-H loop of the VP1 
protein (amino acids 133 to 156) is shown; the epitope defined by mAb SD6 is underlined. The sequence RGDL involved in 
integrin recognition is boxed. Below the mAb SD6 epitope sequence, the amino acid replacements found in individual biological 
FMDV clones isolated as mAb SD6-escape mutants whose corresponding mutations have been analysed in the microarray, are 
indicated. The discontinuous line at the bottom indicates a double mutant. Based in [11, 13, 44] and references therein.
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clease, and labeled with Alexa Fluor 647 as detailed in
Methods. The labeled DNA was hybridized in the micro-
array, as described in Methods.
Five oligonucleotides were designed to identify the wild-
type C-S8c1 sequence at the following positions: 139
(S139), 142 and 143 (RGD), 144 (L144), 146 (H146) and
147 (L147). In the RGD panel good signal intensity was
obtained at four of the positions tested (Figure 4); only
the hybridization with S139 oligonucleotide produced a
low signal.
Four mutants at position 139 were tested. Each mutant
could be identified due to a high signal in the perfect
match probe. No crosshybridization with G139t, G139c
or S139 was detected (Figure 4b).
Two point mutants at VP1 position 142, RRD and RED, as
well as a double mutant for the 142 and 143 positions
Oligonucleotides printed on the microarray for the screening of SD6 epitope C-S8c1 FMDV variants Figure 2
Oligonucleotides printed on the microarray for the screening of SD6 epitope C-S8c1 FMDV variants. Top: 
Amino acid and nucleotide sequence encoding the epitope defined by mAb SD6 in FMDV C-S8c1 VP1, between codons 136 
and 149. The column on the left shows the names of the oligonucleotides used in this work depicted as colored boxes on the 
right; the boxes in green represent oligonucleotide sequences identical to the wild type nucleotide sequence written at the top; 
the boxes in blue represent the oligonucleotides with a sequence corresponding to the different mAb SD6-scape mutants; the 
boxes in yellow represent oligonucleotide sequences used as negative hybridization controls. Colored, empty boxes include 
the wild type nucleotide. The mutations are specified in the corresponding position. The enquired position is located at the 
center of the oligonucleotide. The column on the right gives the predicted Tm value for each oligonucleotide, calculated 
according to Tm = 69.5 + 0.41 × (X%G+C)-650/total nucleotide number. The origin of the different mutations analysed is given 
in Methods and in Figure 1.
Fig.2
 SD6 epitope aa position Tm (ºC)
C - S 8 c 1  ( N - C ,  a a ) YTASARGDLAHLTT
C - S 8 c 1  ( 5 ' - 3 ' ,  n t ) TACACCGCCAGTGCACGCGGGGATTTGGCTCACCTAACGACG
S139-wt 56.2
S139G G 58.9
G139t T 56.2
G139c C 58.9
S139I T 53.5
S139N A 53.5
S139T C 56.2
RGD-wt 53.5
RRD A 50.7
RRDt T 50.76
RRDc C 53.5
RED A 50.7
REDt T 50.7
REDc C 53.5
REG AG 53.5
REGat A T 50.7
REGac A C 53.5
RGG G G 56.2
REGtg T G 53.5
REGcg C G 56.2
RGN A 50.7
RGNt T 50.7
RGNc C 53.5
RGV T 53.5
RGE A 53.5
RGEc C 56.2
L144-wt 50.7
L144g G 53.5
L144a A 50.7
L144S C 53.5
L144V G 53.5
H146-wt 48.0
H146R G 50.7
H146t T 48.0
H146P C 50.7
L147-wt 50.7
L147P C 53.5
P147a A 50.7
148 149 144 145 146 147 140 141 142 143 136 137 138 139BMC Genomics 2006, 7:117 http://www.biomedcentral.com/1471-2164/7/117
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(REG), were available for testing. Hybridizations with
each mutant generated positive signals with the wild-type
oligonucleotides that did not include positions 142 and
143. However, hybridizations were positive with the
probe that identified specifically each mutant, but not
with the probe that represented the wild-type RGD
sequence (Figure 4b).
Position 143 is represented by four SD6-escape mutants:
RGG, RGN, RGV and RGE. Each of them, as well as substi-
tutions at position 144 (Figure 4b), produced the
expected signal. Substitutions at position 144 were per-
fectly discriminated with the oligonucleotides designed in
the microarray (Figure 4) with a slightly weak signal with
the S139 probe. The three mutants analyzed at positions
146 and 147, named H146R, H146P and L147P, showed
an adequate signal for specific identification, and no
crosshybridization with other probes at the same posi-
tion.
The results (Figure 4b) indicate a good discrimination
between positive and negative signals as well as strong sig-
nals in the ICF probe and no signal in any of the negative
controls (HIVa HIVb and nn probes), as expected from the
perfect match and mismatch hybridization signals,
respectively. However, the hybridization pattern of a
mutant includes specific negative and positive signals as
well as crosshybridization signals, which are of different
intensity depending on the hybridization kinetics of each
probe and target. Therefore, an array classification
method was developed to evaluate the hybridization sig-
nals.
Scheme of the successive steps from the copying of FMDV genomic RNA to scanning of the microarray Figure 3
Scheme of the successive steps from the copying of FMDV genomic RNA to scanning of the microarray. RT-
PCR was performed using primers 1R1L (phosphorylated at its 5'-end) and pUL; their sequences are given in Methods. Green 
boxes indicate those steps for which a number of variables were tested; details on the results of such variable screening will be 
provided upon request. The final protocol used for the different steps is detailed in Methods.
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Display of oligonucleotides on the microarrays and microarray hybridization patterns of 16 mAb SD6-escape mutants of FMDV Figure 4
Display of oligonucleotides on the microarrays and microarray hybridization patterns of 16 mAb SD6-escape 
mutants of FMDV. a. Forty-one oligonucleotides (50 µM) were spotted in duplicate, as indicated by dotted circles in the top 
left box of the top left grid; each box in the grid includes the name of a oligonucleotide (sequence given in Figure 2) or negative 
controls (HIVa, HIVb and nn). Oligonucleotides are distributed in 4 rows and 12 columns. An oligonucleotide representing the 
conserved sequence 5'-CCTAGGCCGATTCTTCCG-3', C-S8c1 genomic residues 3757 to 3775 was used as a positive con-
trol of hybridization (termed ICF, Internal Control of FMDV). The ICF oligonucleotide was printed on the left top and right 
bottom corners of the grids, as indicated. The pattern was printed four times in each microarray. b. Each panel represents a 
microarray image, given by the Alexa Fluor 647 fluorescence signal, after hybridization, washing and scanning, as detailed in 
Methods. The distribution of oligonucleotide probes in each array is identical to that given in a. The name of the target 
sequence is written at the left top of each panel; the nucleotide sequence of the different targets is given in Figure 2. Positions 
expected to give a positive signal (perfect match) are underlined. Positions indicated by a dotted line show a mismatch hybridi-
zation but not in the central position. A weak signal due to crosshybridization is expected in these probes.BMC Genomics 2006, 7:117 http://www.biomedcentral.com/1471-2164/7/117
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Microarray quantification and quality control of 
hybridization signals
Procedures for microarray quantification, quality control
of hybridization intensities, and data classification were
applied to the microarray signals, as described in Meth-
ods. Jack-knife tests yielded a class averaged classification
accuracy of 98.7 ± 2.4%. Table 1 shows classification accu-
racy per variant. Most variants are predicted above 95%
accuracy. Exceptions include phenotypes RGE1 and RGV,
with about 93% prediction accuracy. In order to study the
distribution of errors, a confusion matrix is shown in
Table 2. The matrix reveals that the small fraction of errors
observed shows a systematic distribution. Thus, misclassi-
fied RGE samples are systematically classified as S139T
samples, while a misclassified RGV sample is classified
within the RGD variant, and a misclassified V144 sample
is assigned to the RED mutant. Most likely, the observed
errors have their origin in hybridization artefacts, and will
probably be corrected in future versions of the chip. Nev-
ertheless the achieved accuracy is already satisfactory in all
cases for practical applications.
The raw data corresponding to this paper are provided as
additional files ' [see Additional file1]' and can be found
also in [28].
Discussion
A microarray-based method to type representatives of the
seven serotypes of FMDV has been developed by Baxi and
colleagues [17]. The microarray contained 155 oligonu-
cleotide probes, of 35 to 45 residues from the VP3-VP1-
2A-coding region of the FMDV genome. We have now
used a specific approach based on a microarray platform
aimed at distinguishing point mutants within an impor-
tant determinant of antigenicity and host cell tropism,
namely the G-H loop of capsid protein VP1 (Figures 1 and
2). Several preliminary experiments showed a notorious
decrease in the quality of results using aldehyde coated
slides, streptavidine coated magnetic beads to obtain sin-
gle-stranded DNA or a formamide hybridization solution.
Additionally, other conditions involving nucleotide
probes of different length, presence or absence of spacers
between the array substrate and the probe, and different
labeling and hybridization conditions were tested. The
best signal to noise ratios and the most reproducible
results were achieved using 15-mer with oligo (dT)15
spacer and 50 µM concentrated oligonucleotide probes,
with the queried position located towards the center of
the probe, printed of super-epoxi-coated slides (experi-
mental conditions detailed in Methods). Hybridization
and washing temperatures were also selected after system-
atic preliminary experiments.
To assess the reproducibility of the results, the classifica-
tion accuracy was evaluated statistically using jack-knife
simulations. This procedure revealed a high and stable
degree of classification accuracy, although 2 variants were
misclassified in more than 5% of cases. This was probably
due to heterogeneity in the intensity of the hybridization
reactions (Table 1 and 2). Despite this limitation in the
reliable identification of some variants, the results illus-
trate the feasibility of a microarray approach to diagnose
specific virus variants that may be associated with altered
biological behaviors. Thus, the queried mutation was
accurately discriminated from other mutations at the
same site (Figure 4). In particular, the conserved L147 in
VP1 is thought to be essential for integrin recognition of
FMDV [29], and several substitutions at position 147
affect the interaction of FMDV of serotype C with antibod-
ies. A variant with substitution L147P was isolated from a
lesion of partially immunized cattle and had a profound
effect on the antigenicity and tropism of FMDV [23]. This
important L147P variant was correctly detected by the
microarray. Crosshybridizations were observed with the
probes to identify mutations that affect VP1 positions 142
and 143 (Figure 4b), expected from the high degree of
overlap among these probes. This crosshybridization can
be defined as the signal obtained when at least 9 nucle-
otides of a probe are perfect match with the target. For
instance, mutant RGN shows a weak signal with the RGG
probe, and the RGE mutant with the L144 probe. The two
Table 1: Summary of the data set and classification results. 
Average accuracy for each class (Av.class.acc.), i.e, the average 
of the number of successfully classified samples divided by the 
number of classified samples in 100 rounds of jack-knife, and its 
standard deviation (St.dev.class.acc.) are shown for each 
phenotype. The total number of samples in each class (#samples) 
is also given.
Phenotype #samples Av.class.acc. St.dev.class.acc.
RGD 25 1.000 0.000
RED 14 1.000 0.000
REG 9 1.000 0.000
S144 6 1.000 0.000
V144 15 0.967 0.034
S139N 17 0.993 0.020
S139T 15 0.982 0.038
RRD 6 1.000 0.000
RGN 13 1.000 0.000
RGV 8 0.926 0.062
H146P 12 1.000 0.000
RGG 11 1.000 0.000
L147P 6 1.000 0.000
S139G 10 1.000 0.000
H146R 9 0.996 0.044
S139I 15 0.987 0.028
RGE1 11 0.927 0.040
Total 202 - -
Average 11.882 0.987 0.016
SD 4.833 0.024 0.021BMC Genomics 2006, 7:117 http://www.biomedcentral.com/1471-2164/7/117
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amino acids replaced in those variants are also essential
for integrin recognition of FMDV [29].
Despite the bulk of microarray technology being used to
define patterns of gene expression, increasing applications
are found in the detection of genetic polymorphisms [30-
32]. The application to discriminate among variants of
FMDV is added to a number of microarray procedures
used in virology to analyze multiple viral pathogens that
belong to different virus families [18,33], to detect specific
viruses [34-36] or to define genetic variations underwent
by viruses [37,38] [reviews in [39,40]]. Microarray tech-
nology has been also used to probe differences in the
structure of hepatitis C virus RNA, that result from genetic
differences that may be associated with different
responses to interferon treatment [41].
The distinction among mutants of the same virus is
becoming increasingly necessary in view of the extensive
variation among representatives of most virus groups
[42], the quasispecies population structure of RNA viruses
and some DNA viruses [8], and the increasing recognition
that one or a limited number of mutations in a viral
genome can have a profound effect in its biological behav-
ior [reviews in [8,10,24]]. In this report, we have docu-
mented that DNA microarray technology can be used as a
high-throughput method to analyze polymorphisms
within a short region of the FMDV genome, and have suc-
cessfully devised a SVM-based method to classify the sam-
ples on the basis of their hybridization signal. The
procedure is of general applicability as a test for specificity
and discriminatory power of microarray-based diagnostic
procedures using multiple probes. We are currently inves-
tigating an extension of the same methodology to detect
minority genomes in viral populations, as a means to
quantify mutant spectrum complexity, and to evaluate
memory levels in viral quasispecies [8,10,24].
Conclusion
In the current study, we have documented that DNA
microarray technology can be used as a high-throughput
method to analyze polymorphisms within a short region
of the FMDV genome encoding relevant functions in anti-
genicity and receptor recognition. We have successfully
devised a support vector machine (SVM)-based method to
classify the samples on the basis of their hybridization sig-
nal. The bioinformatic procedure is of general applicabil-
ity to fine genotyping, including studies of heterogeneous
viral populations, genetic changes in virus, bacteria, and
genes of rapidly evolving cells, such as tumoral cells.
Methods
Cell culture and origin of FMDV mutants
Procedures for cell culture, infections with FMDV in liq-
uid medium or in semisolid agar medium for titration of
infectivity have been previously described [43]. FMDV
biological clone C-S8c1, derived from natural isolate C-
Sta Pau Sp/70 [43] was serially passaged 100 times in
BHK-21 cells at a multiplicity of infection of 2–4 plaque-
forming-units (PFU) per cell; this yielded population C-
S8c1p100. Individual FMDV mutants with nucleotide
substitutions at the genomic region encoding the G-H
loop of VP1 were isolated by selecting escape mutants
resistant to monoclonal antibody (mAb) SD6, which rec-
ognizes amino acids 138 to 147 of VP1 [44] (Figure 1).
The populations used to select mAb SD6-resistant
mutants were derived from C-S8c1p100, in experiments
designed to test duration of quasispecies memory [45].
Procedures to select mAb SD6-resistant mutants were
described previously [44,46,47].
Table 2: Confusion matrix. Fraction of samples of each phenotype class classified in any other class (row-wise mode). Non zero values 
are highlighted in bold (see Methods).
Genot. RGD RED REG S144 V144 S139N S139T RRD RGN RGV H146P RGG L147P S139G H146R S139I RGE1
RGD 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
RED 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
REG 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
S144 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
V144 0.000 0.032 0.000 0.000 0.968 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
S139N 0.002 0.000 0.000 0.000 0.000 0.993 0.004 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001 0.000
S139T 0.000 0.000 0.000 0.000 0.000 0.016 0.983 0.000 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
RRD 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
RGN 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
RGV 0.069 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.925 0.000 0.006 0.000 0.000 0.000 0.000 0.000
H146P 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000 0.000
RGG 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000 0.000
L147P 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000 0.000
S139G 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 1.000 0.000 0.000 0.000
H146R 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.002 0.002 0.000 0.000 0.996 0.000 0.000
S139I 0.005 0.000 0.000 0.000 0.000 0.005 0.003 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.987 0.000
RGE1 0.001 0.000 0.000 0.000 0.000 0.000 0.068 0.002 0.002 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.927BMC Genomics 2006, 7:117 http://www.biomedcentral.com/1471-2164/7/117
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Microarray design and printing
Thirty eight DNA oligonucleotides, corresponding to the
C-S8c1 genomic region encoding residues 139 to 147
(Figure 1) were designed and synthesized (Sigma). They
included a 'C6 amino linker' [NH2 (CH2)6] at their 5'-end,
followed by an oligo (dT)15 spacer and the specific 15-mer
sequence; the oligonucleotides were purified by HPLC.
The oligonucleotides (Figure 2) were selected to have a
similar melting temperature when annealed to a comple-
mentary sequence, and included the queried nucleotide at
the central region of the specific 15-mer. A conserved
FMDV sequence, located between genomic residues 3757
and 3775 (5'-C6-T15CCTAGGCCGATTCTTCCG-3', within
the VP1-coding region) [the numbering of FMDV
genomic residues is according to [48]] was used as posi-
tive control for the hybridization (ICF, Internal Control
FMDV). Two unrelated oligonucleotides (5'-C6-
T15CAATACATGGATGATT-3' and 5'-C6-
T15GATGCATATTTTTCAG-3', corresponding to the HIV
reverse transcriptase coding region and termed HIVa and
HIVb respectively) and spots with spotting solution with
no nucleotide (nn in Figure 4) were used as negative con-
trols. The oligonucleotides were diluted in 1 × spotting
solution (Telechem-Arrayit) at 50 µM final concentration,
and spotted onto super-epoxy-coated glass slides (Tel-
echem-Arrayit).
Microarrays containing 384 spots were printed by means
of a GMS 417 DNA arrayer (Affymetrix) defining four
grids per slide. Each oligonucleotide was spotted in dupli-
cate dots 150 µm in diameter, with a center-to-center dis-
tance of 250 µm (Figure 3).
In a number of preliminary assays, 11-mer and 15-mer
oligonucleotides at concentrations of 5, 25 and 50 µM,
and with or without an oligo (dT)15 spacer at the 5'-end
were compared; the final protocol corresponds to the set
of materials and conditions showing the highest sensitiv-
ity and reproducibility, among the conditions tested.
Preparation of target DNAs
RNA from mAb SD6-escape mutants [45] was extracted
using Trizol (Invitrogene), as previously described [48].
RNA was reverse transcribed using avian myeloblastosis
reverse transcriptase (RT) and pUL as primer (5'-GAGAA-
GAAGAAGGCCCAGGGTG-3'; antisense primer, comple-
mentary to positions 3873 to 3896 of the FMDV C-S8c1
genome). PCR amplification of the cDNA was performed
using Expand High Fidelity polymerase (Roche), as speci-
fied by the manufacturers; the primers used were 1R1L (5'-
ACACCGTGTGTTGGCTACGGCG-3'; sense primer, corre-
sponding to FMDV C-S8c1 genomic residues 3573 to
3594; phosphorylated at its 5'-end) and pUL. Each of the
RT-PCR products was analyzed by nucleotide sequencing
using the Big Dye Terminator Cycle Sequencing Kit (Abi
Prism, Perkin Elmer) and the automated sequencers ABI
373 or ABI 3700, to ensure the presence of the mAb-
escape mutation. The phosphorylated strand was specifi-
cally degraded using lambda exonuclease (New England
Biolabs), and the resulting single-stranded DNA was
labeled with Alexa Fluor 647 using the U-21660 Ulysis
Nucleic Acid Labeling Kit (Molecular Probes). The labeled
DNA was used as target in the hybridization with the
probe oligonucleotides on the microarrays.
In a number of preliminary assays, a streptavidin-biotin
system was assessed to obtain single-strand DNA target
(AffiniTip Strep, -Hydros). Additionally, Cy3 and Cy5 flu-
orescence dyes (Amersham) were used as a direct labeling
system. The final protocol includes the reagents showing
in our hands the highest sensitivity and reproducibility.
Hybridization and scanning
Immediately before hybridization, slides were processed
as follows: They were washed for 2 min. at room temper-
ature with 2X sodium saline citrate (SSC), 0.1% lauroyl-
sarcosine, and for an additional 2 min. wash with 2 × SSC
at room temperature, to remove unbound DNA and com-
ponents of the printing buffer. The oligonucleotides were
denatured by placing the slides 2 min. in distilled water at
100°C, cooled 10 sec. at room temperature, and then the
oligonucleotides were fixed by plunging the slides into
ice-cold 100% ethanol for 2 min., finally the slides were
centrifuged 1 min. at 500 × g (Minicentrifuge Arrayit).
Microarrays were incubated in a hybridization chamber
(Genetix) with 20 µl of hybridization buffer (6 × SSC,
0.5% SDS, 1% BSA) under a 24 × 24 mm cover slip, and
bathed at 42°C for 45 min. Then the microarrays were
washed with distilled water, and dried by a brief centrifu-
gation.
The hybridization with the labeled DNA was carried out
in hybridization buffer at the appropriate temperature
(58–60°C) and with the required amount of target (0.3
pmoles Alexa Fluor 647 equivalent to 50 ng). After a 3
hours incubation in the hybridization chamber, the slides
were washed for 5 min. in 2 × SSC, 0.1% lauroylsarcosine,
followed by 5 min. in 2 × SSC, and finally rinsed 10 sec.
in 0.2 × SSC, and 5 min. in distilled water, at 45°C. The
slides were dried by spinning 1 min. at 500 × g and,
finally, scanned using a G2565AA/G2565AB Scanner
(Agilent). The Agilent and Scan Array Express (Perkin
Elmer Life Sciences) analysis software was used for read-
ing and quantifying the hybridization images. The repro-
ducibility of the method was assessed by comparing the
results of at least five different hybridization experiments
for each mutant.BMC Genomics 2006, 7:117 http://www.biomedcentral.com/1471-2164/7/117
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Data pre-processing
Array quantification was performed with the program
Scan Array Express. Each probe was duplicated in the
array. For each spot in the array, measures for the mean
and median foreground intensity and for the mean and
median background intensities were available. Visual
inspection of scanned hybridized arrays revealed some
noise due to the presence of dust and scratches, introduc-
ing an uneven increase in the mean foreground signal for
some spots. We have tried to detect the affected spots by
calculating a Z-score of their mean foreground intensity
per pixel, using the four measurements available for each
probe in every hybridization experiment. For this, we have
used the additional measures available for the same probe
(median foreground intensity and replicated spot mean
and median foreground intensity) and computed their
average and standard deviation. Then we calculated the Z-
score in the usual way, subtracting the average from the
mean foreground intensity and then dividing it by the
standard deviation. After testing several absolute Z-score
thresholds for discarding spots, we have found that a Z-
score of 7 provides optimal results. If neither of the spots
is discarded, we take as a measure for the presence of each
mutant in the sample (Ma), the log2 of the average of its
replicated spots mean foreground intensities, subtracted
from its background:
where Ia1 and Ia2 are the mean foreground pixel intensities
and Ba1 and Ba2 are the mean background pixel intensities
for spot 1 and spot 2 of the probe for variant a, respec-
tively. In case one of the spots is discarded, we take Ma as
the log2 of the remaining spot mean foreground intensity
subtracted from its mean background intensity.
As a hybridization quality control, we added a probe for a
fully conserved region of VP1 of the FMDV (ICF), discard-
ing those arrays for which the log2 of the average intensity
for this probe was under 7, in our experience a threshold
that distinguishes arrays with hybridization problems
from the normal ones. We tried several normalization
conditions as taking the square root of the average spots
mean intensities instead of the log2 or making a prior nor-
malization by dividing each Ma by MICF, but final classifi-
cation accuracy was optimal at the conditions reported.
Data classification
Data classification was carried out with a multiple class
support vector machine tool (mcSVM) [49,50]. Briefly, a
SVM is a supervised learning algorithm [51]. It belongs to
the class of methods that solve the general problem of
learning discriminative boundaries, able to optimally sep-
arate positive and negative members of a given set of
points in a n-dimensional vector space. The SVM algo-
rithm operates by first mapping the training set into a
high-dimensional feature space and then attempting to
locate in that space a hyperplane that separates positive
from negative examples. Having found such a hyperplane,
the SVM can then predict the classification of an unla-
beled example by mapping it into the feature space and
asking on which side of the separating plane the example
is found. The multiclass SVM is an extension of the classi-
fication problem to multiple classes, instead of just a
binary classification.
In our case, we have used 39 probes in the array for classi-
fication purposes, one for quality control ICF and 38 for
detecting different genotypes, including mutants and wild
type. Therefore, each sample was encoded by a 39 dimen-
sional vector, each dimension corresponding to a variable
computed in equation 1. We analyzed 202 samples dis-
tributed among 17 phenotype classes to classify (Table 1).
We ensured that at least 6 samples were available for each
variant (Table 1). We applied mcSVM to this problem,
using a Gaussian kernel which yielded γ = 10-2 and α = 103
as optimal parameters.
Assessing the classifier
In order to test the prediction capabilities of the method,
we applied a jack-knife test. We assigned randomly the
samples to 10 different groups. Each one of the groups,
with 10% of the samples, was used as a test set, while the
remaining 90% was used as a training set. We then meas-
ured the fraction of correctly predicted samples by mcSVM
in the test. The procedure was repeated for all groups,
completing in this way one round of testing. 100 rounds
were simulated, each time with a different random distri-
bution of samples in the groups. We averaged out the frac-
tion of correctly predicted samples to obtain the final
quality of the classifier. We also built a confusion table in
order to study the presence of systematic errors in the
cases that failed (Table 2). This table shows in a row-wise
mode the fraction of samples of each phenotype variant
classified in any other variants.
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